KRMD vs INFU vs AVNS vs BDX vs BAX

For growth investors, KORU Medical Systems, Inc.

(KRMD) is the stronger pick with 22. 2% revenue growth year-over-year, versus 1. 9% for Avanos Medical, Inc. (AVNS). Becton, Dickinson and Company (BDX) offers the better valuation at 26. 3x trailing P/E (12. 3x forward), making it the more compelling value choice. Analysts rate KORU Medical Systems, Inc. (KRMD) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Becton, Dickinson and Company (BDX) is the cheapest at 26.

3x versus InfuSystem Holdings, Inc. at 28. 9x. On forward P/E, Baxter International Inc. is actually cheaper at 9. 2x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, KORU Medical Systems, Inc.

(KRMD) delivered a total return of +24. 0%, compared to -74. 3% for Baxter International Inc. (BAX). Over 10 years, the gap is even starker: KRMD returned +1116% versus BAX's -42. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Becton, Dickinson and Company (BDX) is the lower-risk stock at 0.

66β versus Avanos Medical, Inc. 's 1. 54β — meaning AVNS is approximately 135% more volatile than BDX relative to the S&P 500. On balance sheet safety, InfuSystem Holdings, Inc. (INFU) carries a lower debt/equity ratio of 6% versus 164% for Baxter International Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), KORU Medical Systems, Inc.

(KRMD) is pulling ahead at 22. 2% versus 1. 9% for Avanos Medical, Inc. (AVNS). On earnings-per-share growth, the picture is similar: InfuSystem Holdings, Inc. grew EPS 181. 8% year-over-year, compared to -37. 8% for Baxter International Inc.. Over a 3-year CAGR, KRMD leads at 13. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Becton, Dickinson and Company (BDX) is the more profitable company, earning 7.

7% net margin versus -9. 7% for Avanos Medical, Inc. — meaning it keeps 7. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BDX leads at 11. 8% versus -8. 8% for AVNS. At the gross margin level — before operating expenses — KRMD leads at 60. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Baxter International Inc.

(BAX) trades at 9. 2x forward P/E versus 24. 8x for Avanos Medical, Inc. — 15. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INFU: 67. 4% to $15. 00.

In this comparison, BAX (3.

9% yield), BDX (2. 7% yield) pay a dividend. KRMD, INFU, AVNS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Becton, Dickinson and Company (BDX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

66), 2. 7% yield). Avanos Medical, Inc. (AVNS) carries a higher beta of 1. 54 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BDX: +80. 2%, AVNS: -17. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: KRMD is a small-cap high-growth stock; INFU is a small-cap quality compounder stock; AVNS is a small-cap quality compounder stock; BDX is a mid-cap quality compounder stock; BAX is a small-cap income-oriented stock. BDX, BAX pay a dividend while KRMD, INFU, AVNS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.